Serotonin metabolism is dysregulated in cholangiocarcinoma, which has implications for tumor growth.

Abstract:

:Cholangiocarcinoma is a devastating cancer of biliary origin with limited treatment options. Symptoms are usually evident after blockage of the bile duct by the tumor, and at this late stage, they are relatively resistant to chemotherapy and radiation therapy. Therefore, it is imperative that alternative treatment options are explored. We present novel data indicating that the metabolism of serotonin is dysregulated in cholangiocarcinoma cell lines, compared with normal cholangiocytes, and tissue and bile from cholangiocarcinoma patients. Specifically, there was an increased expression of tryptophan hydroxylase 1 and a suppression of monoamine oxidase A expression (enzymes responsible for the synthesis and degradation of serotonin, respectively) in cholangiocarcinoma. This resulted in an increased secretion of serotonin from cholangiocarcinoma and increased serotonin in the bile from cholangiocarcinoma patients. Increased local serotonin release may have implications on cholangiocarcinoma cell growth. Serotonin administration increased cholangiocarcinoma cell growth in vitro, whereas inhibition of serotonin synthesis decreases tumor cell growth both in vitro and in vivo. The data presented here represent the first evidence that serotonin metabolism is dysregulated in cholangiocarcinoma and that modulation of serotonin synthesis may represent an alternative target for the development of therapeutic strategies.

journal_name

Cancer Res

journal_title

Cancer research

authors

Alpini G,Invernizzi P,Gaudio E,Venter J,Kopriva S,Bernuzzi F,Onori P,Franchitto A,Coufal M,Frampton G,Alvaro D,Lee SP,Marzioni M,Benedetti A,DeMorrow S

doi

10.1158/0008-5472.CAN-08-2133

subject

Has Abstract

pub_date

2008-11-15 00:00:00

pages

9184-93

issue

22

eissn

0008-5472

issn

1538-7445

pii

68/22/9184

journal_volume

68

pub_type

杂志文章
  • Functional CXCR4-expressing microparticles and SDF-1 correlate with circulating acute myelogenous leukemia cells.

    abstract::Stromal cell-derived factor-1 (SDF-1/CXCL12) and its receptor CXCR4 are implicated in the pathogenesis and prognosis of acute myelogenous leukemia (AML). Cellular microparticles, submicron vesicles shed from the plasma membrane of various cells, are also associated with human pathology. In the present study, we invest...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-2006

    authors: Kalinkovich A,Tavor S,Avigdor A,Kahn J,Brill A,Petit I,Goichberg P,Tesio M,Netzer N,Naparstek E,Hardan I,Nagler A,Resnick I,Tsimanis A,Lapidot T

    更新日期:2006-11-15 00:00:00

  • Effect of subcutaneously administered 2,6,10,14-tetramethylpentadecane on plasmacytoma growth.

    abstract::2,6,10,14-Tetramethylpentadecane (pristane), s.c. injected simultaneously with plasmacytoma inocula, enhances the transplantability of tumor cells. The effect is dose and time dependent. The enhancement is shown only by plasmacytoma (MOPC-315 and MPC-11) and not by the murine lymphosarcoma and chondrosarcoma tested. V...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Platica M,Bojko C,Steiner G,Hollander VP

    更新日期:1980-07-01 00:00:00

  • Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma.

    abstract::Recent in vitro studies of the epidermal growth factor receptor (EGFR) family have revealed complex signaling interactions involving the production of ligand-mediated heterodimers synergistic for the transformation of cells in vitro. In a series of 70 patients with childhood medulloblastoma, we have used immunohistoch...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gilbertson RJ,Perry RH,Kelly PJ,Pearson AD,Lunec J

    更新日期:1997-08-01 00:00:00

  • TRAIL receptor-selective mutants signal to apoptosis via TRAIL-R1 in primary lymphoid malignancies.

    abstract::Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its agonistic antibodies, which are currently in early clinical trials for treating various malignancies, induce apoptosis through triggering of either TRAIL-R1 or TRAIL-R2. Based on studies using agonistic monoclonal antibodies, we recently proposed ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-2801

    authors: MacFarlane M,Kohlhaas SL,Sutcliffe MJ,Dyer MJ,Cohen GM

    更新日期:2005-12-15 00:00:00

  • Increased amounts of double-stranded RNA in the cytoplasm of rat liver following treatment with carcinogens.

    abstract::Cytoplasmic RNA was isolated from control rats or at 48 hr following carcinogen administration. A significant quantity (0.6%) of double-stranded RNA was present in control preparations, as assessed by digestion with RNase III. Following carcinogen treatment of rats, this percentage increased significantly. The results...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Clawson GA,Smuckler EA

    更新日期:1982-08-01 00:00:00

  • Increased gastrointestinal absorption of large molecules in patients after 5-fluorouracil therapy for metastatic colon carcinoma.

    abstract::Chemotherapeutic agents may damage gastrointestinal epithelium and thereby impair the mucosal barrier to bacteria and their products. In order to obtain an objective measurement of gastrointestinal permeability to large molecules, we measured urinary excretion of [14C]polyvinylpyrrolidone administered p.o. (mean molec...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Siber GR,Mayer RJ,Levin MJ

    更新日期:1980-10-01 00:00:00

  • Effect of the antineoplastic agent methotrexate on experimental heterotopic new bone formation in rats.

    abstract::Heterotopic new bone formation was induced by implanting pieces of demineralized bone matrix in the abdominal wall of 22 growing Sprague-Dawley rats. The animals were divided into three groups and were given, 24 hr after initiation of the bone induction process, a single i.v. injection of methotrexate, 100 or 250 mg/k...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Nilsson OS,Bauer FC,Broström LA,Nilsonne U

    更新日期:1984-04-01 00:00:00

  • Targeted cancer therapeutics.

    abstract::Targeted therapies can be defined as drugs developed against a specific target based on its important biological function in cancer. In contrast, nontargeted therapies are drugs identified by phenotypic screening of natural products or chemical libraries against established cancer cell lines or preclinical animal mode...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-08-3836

    authors: Hait WN,Hambley TW

    更新日期:2009-02-15 00:00:00

  • Role of ligand exchange processes in the reaction kinetics of the antitumor drug cis-diamminedichloroplatinum(II) with its targets.

    abstract::The kinetics of a model reaction between the antitumor drug cis-diamminedichloroplatinum(II)(cis-DDP) and the signal nucleotide diadenosine 5',5"'-P1,P4-tetraphosphate (Ap4A) has been investigated by spectrophotometry. The formation of the reactive platinum aquated species was first analyzed by potentiometry using a c...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Segal E,Le Pecq JB

    更新日期:1985-02-01 00:00:00

  • p190RhoGEF (Rgnef) promotes colon carcinoma tumor progression via interaction with focal adhesion kinase.

    abstract::Focal adhesion kinase (FAK) functions downstream of integrins and growth factor receptors to promote tumor cell motility and invasion. In colorectal cancer, FAK is activated by amidated gastrin, a protumorigenic hormone. However, it is unclear how FAK receives signals from the gastrin receptor or other G-protein-coupl...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-2894

    authors: Yu HG,Nam JO,Miller NL,Tanjoni I,Walsh C,Shi L,Kim L,Chen XL,Tomar A,Lim ST,Schlaepfer DD

    更新日期:2011-01-15 00:00:00

  • Bovine serum albumin-doxorubicin conjugate overcomes multidrug resistance in a rat hepatoma.

    abstract::A bovine serum albumin-conjugated doxorubicin via the glutaraldehyde bridge (BSA-DXR conjugate) showed potent dose-dependent inhibition of cell growth against daunorubicin-resistant AH66 (AH66DR) cells as well as parental AH66 (AH66P) cells in vitro as compared to treatment with DXR or BSA-glutaraldehyde conjugate wit...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ohkawa K,Hatano T,Yamada K,Joh K,Takada K,Tsukada Y,Matsuda M

    更新日期:1993-09-15 00:00:00

  • Synergistic effects of new chemopreventive agents and conventional cytotoxic agents against human lung cancer cell lines.

    abstract::Non-small cell lung cancer (NSCLC) cells have constitutively high expression of cytosolic phospholipase A2 (cPLA2) and cyclooxygenase (COX) 2. These NSCLC cells also have increased prostaglandin expression (PGE2). Many lung cancers also express 12-lipoxygenase RNA and 12-lipoxygenase protein and biosynthesize 12(S)-hy...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Soriano AF,Helfrich B,Chan DC,Heasley LE,Bunn PA Jr,Chou TC

    更新日期:1999-12-15 00:00:00

  • DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor.

    abstract::DDX3 is a DEAD box RNA helicase with diverse biological functions. Using colony formation assay, our results revealed that DDX3 inhibited the colony formation ability of various tumor cells, and this inhibition might be due to a reduced growth rate caused by DDX3. Additionally, we identified p21(waf1/cip1), a cyclin-d...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-2415

    authors: Chao CH,Chen CM,Cheng PL,Shih JW,Tsou AP,Lee YH

    更新日期:2006-07-01 00:00:00

  • Suramin suppresses hypercalcemia and osteoclastic bone resorption in nude mice bearing a human squamous cancer.

    abstract::Suramin is a polyanionic agent which has been found to be an effective antineoplastic agent against various human tumors including adrenal, renal and prostatic cancer, and osteosarcoma. Recently, suramin has been shown to inhibit bone resorption in organ cultures of mouse calvarial bones. In the present study, we exam...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Yoneda T,Williams P,Rhine C,Boyce BF,Dunstan C,Mundy GR

    更新日期:1995-05-01 00:00:00

  • Enrichment of collagen and gelatin degrading activities in the plasma membranes of human cancer cells.

    abstract::Interactions between connective tissue substrates and proteinases localized to the surface of cancer cells are implicated in cancer invasion. In this report we have compared the enrichment of collagen and gelatin degrading activities and cysteine proteinase(s) in well-characterized (enzyme markers and electron microsc...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Zucker S,Wieman JM,Lysik RM,Wilkie D,Ramamurthy NS,Golub LM,Lane B

    更新日期:1987-03-15 00:00:00

  • Rapid analysis of distinctive CD44 RNA splicing preferences that characterize colonic tumors.

    abstract::In normal tissues, the steady-state level of CD44 mRNA is low, and the variety of alternatively spliced transcripts produced by this complex gene is limited. Conversely, increased and disorderly expression of this gene has been observed in a number of types of cancer. This study analyzed the order in which the CD44 va...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Goodison S,Yoshida K,Sugino T,Woodman A,Gorham H,Bolodeoku J,Kaufmann M,Tarin D

    更新日期:1997-08-01 00:00:00

  • Limited capability of regional lymph nodes to eradicate metastatic cancer cells.

    abstract::The capacity of lymph nodes to eradicate cancer is a controversial issue. The purpose of this study was to determine the interplay between tumor growth and host resistance at early stages of lymph node metastasis. A metastasis model was made in the rat mesenteric lymph node, and migration of cancer cells was visualize...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-1182

    authors: Nagata H,Arai T,Soejima Y,Suzuki H,Ishii H,Hibi T

    更新日期:2004-11-15 00:00:00

  • Heterozygosity of Chaperone Grp78 Reduces Intestinal Stem Cell Regeneration Potential and Protects against Adenoma Formation.

    abstract::Deletion of endoplasmic reticulum resident chaperone Grp78 results in activation of the unfolded protein response and causes rapid depletion of the entire intestinal epithelium. Whether modest reduction of Grp78 may affect stem cell fate without compromising intestinal integrity remains unknown. Here, we employ a mode...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-17-3600

    authors: van Lidth de Jeude JF,Spaan CN,Meijer BJ,Smit WL,Soeratram TTD,Wielenga MCB,Westendorp BF,Lee AS,Meisner S,Vermeulen JLM,Wildenberg ME,van den Brink GR,Muncan V,Heijmans J

    更新日期:2018-11-01 00:00:00

  • Definition of a FoxA1 Cistrome that is crucial for G1 to S-phase cell-cycle transit in castration-resistant prostate cancer.

    abstract::The enhancer pioneer transcription factor FoxA1 is a global mediator of steroid receptor (SR) action in hormone-dependent cancers. In castration-resistant prostate cancer (CRPC), FoxA1 acts as an androgen receptor cofactor to drive G₂ to M-phase cell-cycle transit. Here, we describe a mechanistically distinct SR-indep...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-11-1882

    authors: Zhang C,Wang L,Wu D,Chen H,Chen Z,Thomas-Ahner JM,Zynger DL,Eeckhoute J,Yu J,Luo J,Brown M,Clinton SK,Nephew KP,Huang TH,Li W,Wang Q

    更新日期:2011-11-01 00:00:00

  • IA-1, a new marker for neuroendocrine differentiation in human lung cancer cell lines.

    abstract::IA-1 is a recently isolated novel complementary DNA which encodes a protein of 510 amino acids that contains both a zinc finger DNA-binding domain and a putative prohormone domain. mRNA expression of IA-1 has been found thus far only in tumors of neuroendocrine origin. In this report we describe the expression of IA-1...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Lan MS,Russell EK,Lu J,Johnson BE,Notkins AL

    更新日期:1993-09-15 00:00:00

  • Critical impact of the kinetics of dendritic cells activation on the in vivo induction of tumor-specific T lymphocytes.

    abstract::Dendritic cells (DCs) need activation for the priming of antigen-specific immune responses. Recently activated DCs were described to prime in vitro strong T helper cell type 1 (Th(1)) responses, whereas at later time points, the same cells preferentially prime Th(2) cells [Langenkemp, A. et al., Nat. Immunol. 1: 311-3...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Camporeale A,Boni A,Iezzi G,Degl'Innocenti E,Grioni M,Mondino A,Bellone M

    更新日期:2003-07-01 00:00:00

  • Differential regulation of cytochrome P450 1A1 and 1B1 by a combination of dioxin and pesticides in the breast tumor cell line MCF-7.

    abstract::Dioxin and pesticides with xenoestrogenic activity are environmental contaminants that are suspected of promoting human diseases such as cancers. However, few studies have addressed the molecular consequences of a combination of these contaminants, a situation that is likely to occur in the environment. We investigate...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Coumoul X,Diry M,Robillot C,Barouki R

    更新日期:2001-05-15 00:00:00

  • Metastasizing neuroblastomas in mice transgenic for simian virus 40 large T (SV40T) under the olfactory marker protein gene promoter.

    abstract::The olfactory marker protein (OMP) is a M(r) 19,000 polypeptide originally considered a selective marker for differentiated olfactory receptor neurons. In an attempt to induce neoplastic proliferation in the olfactory cells, we made mice transgenic for the simian virus 40 large T-antigen gene linked to the OMP gene pr...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Servenius B,Vernachio J,Price J,Andersson LC,Peterson PA

    更新日期:1994-10-01 00:00:00

  • Increase in type I cyclic adenosine 3':5'-monophosphate-dependent protein kinase activity and specific accumulation of type I regulatory subunits in adenovirus type 12-transformed cells.

    abstract::Types I and II cyclic adenosine 3':5'-monophosphate (cAMP)-dependent protein kinases were compared in extracts from untransformed rat 3Y1 cells and 3Y1 cells transformed by the highly oncogenic human adenovirus type 12. Analysis of the kinases through diethylaminoethyl Sepharose column chromatography showed a signific...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ledinko N,Chan IJ

    更新日期:1984-06-01 00:00:00

  • ZMYND8 expression in breast cancer cells blocks T-lymphocyte surveillance to promote tumor growth.

    abstract::Emerging studies indicate that DNA damage in cancer cells triggers antitumor immunity, but its intrinsic regulatory mechanism in breast cancer cells remains poorly understood. Here, we show that ZMYND8 is upregulated and inhibits micronucleus formation and DNA damage in breast cancer cells. Loss of ZMYND8 triggered ac...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-20-1710

    authors: Wang Y,Luo M,Chen Y,Wang Y,Zhang B,Ren Z,Bao L,Wang Y,Wang JE,Fu YX,Luo W,Wang Y

    更新日期:2020-11-04 00:00:00

  • The Tumor Microenvironment at a Turning Point Knowledge Gained Over the Last Decade, and Challenges and Opportunities Ahead: A White Paper from the NCI TME Network.

    abstract::Over the past 10 years, the Tumor Microenvironment Network (TMEN), supported by the NCI (Bethesda, MD), has promoted collaborative research with the explicit goal of fostering multi-institutional and transdisciplinary groups that are capable of addressing complex issues involving the tumor microenvironment. The main g...

    journal_title:Cancer research

    pub_type:

    doi:10.1158/0008-5472.CAN-16-1336

    authors: DeClerck YA,Pienta KJ,Woodhouse EC,Singer DS,Mohla S

    更新日期:2017-03-01 00:00:00

  • RalA and RalB: antagonistic relatives in cancer cell migration.

    abstract::The Ral family of small G proteins has been implicated in tumorigenesis, invasion, and metastasis. However, little emphasis has been placed on clarifying the individual roles of the two Ral proteins, RalA and RalB, in these processes in view of their high sequence homology. Here we analyze the separate contributions o...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-1957

    authors: Oxford G,Owens CR,Titus BJ,Foreman TL,Herlevsen MC,Smith SC,Theodorescu D

    更新日期:2005-08-15 00:00:00

  • A CD44 survival pathway triggers chemoresistance via lyn kinase and phosphoinositide 3-kinase/Akt in colon carcinoma cells.

    abstract::A major obstacle to successful treatment of colorectal cancer is chemotherapy resistance. Enhanced expression of variant CD44 isoforms has been associated with aggressive tumor behavior, prompting the question of whether signaling from this receptor might modulate drug sensitivity. Activation of variant CD44 in colon ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Bates RC,Edwards NS,Burns GF,Fisher DE

    更新日期:2001-07-01 00:00:00

  • Identification of Interacting Stromal Axes in Triple-Negative Breast Cancer.

    abstract::Triple-negative breast cancer (TNBC) is a molecularly heterogeneous cancer that is difficult to treat. Despite the role it may play in tumor progression and response to therapy, microenvironmental (stromal) heterogeneity in TNBC has not been well characterized. To address this challenge, we investigated the transcript...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-16-3427

    authors: Saleh SMI,Bertos N,Gruosso T,Gigoux M,Souleimanova M,Zhao H,Omeroglu A,Hallett MT,Park M

    更新日期:2017-09-01 00:00:00

  • Calcium in milk products precipitates intestinal fatty acids and secondary bile acids and thus inhibits colonic cytotoxicity in humans.

    abstract::Dietary calcium may reduce the risk of colon cancer, probably by precipitating cytotoxic surfactants, such as secondary bile acids, in the colonic lumen. We previously showed that milk mineral, an important source of calcium, decreases metabolic risk factors and colonic proliferation in rats. We now report the effects...

    journal_title:Cancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Govers MJ,Termont DS,Lapré JA,Kleibeuker JH,Vonk RJ,Van der Meer R

    更新日期:1996-07-15 00:00:00